Oral pilocarpine for the treatment of salivary gland dysfunction due to radiotherapy
Oral pilocarpine for the treatment of salivary gland dysfunction due to radiotherapy is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Oral Pilocarpine for the Treatment of Salivary Gland Dysfunction Due to Radiotherapy." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/456503/all/Oral_pilocarpine_for_the_treatment_of_salivary_gland_dysfunction_due_to_radiotherapy.
Oral pilocarpine for the treatment of salivary gland dysfunction due to radiotherapy. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/456503/all/Oral_pilocarpine_for_the_treatment_of_salivary_gland_dysfunction_due_to_radiotherapy. Accessed March 24, 2023.
Oral pilocarpine for the treatment of salivary gland dysfunction due to radiotherapy. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/456503/all/Oral_pilocarpine_for_the_treatment_of_salivary_gland_dysfunction_due_to_radiotherapy
Oral Pilocarpine for the Treatment of Salivary Gland Dysfunction Due to Radiotherapy [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 March 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/456503/all/Oral_pilocarpine_for_the_treatment_of_salivary_gland_dysfunction_due_to_radiotherapy.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Oral pilocarpine for the treatment of salivary gland dysfunction due to radiotherapy
ID - 456503
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/456503/all/Oral_pilocarpine_for_the_treatment_of_salivary_gland_dysfunction_due_to_radiotherapy
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -